Processing

Please wait...

Settings

Settings

Goto Application

1. CA2167044 - ORAL ADMINISTRATION OF EFFECTIVE AMOUNTS OF FORMS OF HYALURONIC ACID

Office
Canada
Application Number 2167044
Application Date 11.01.1996
Publication Number 2167044
Publication Date 12.07.1997
Grant Number
Grant Date 07.08.2001
Publication Kind C
IPC
A61K 31/728
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
726Glycosaminoglycans, i.e. mucopolysaccharides
728Hyaluronic acid
A61K 47/36
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
CPC
A61K 31/728
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
726Glycosaminoglycans, i.e. mucopolysaccharides
728Hyaluronic acid
Applicants TURLEY, EVA ANNE
ASCULAI, SAMUEL SIMON
Inventors TURLEY, EVA ANNE
ASCULAI, SAMUEL SIMON
Title
(EN) ORAL ADMINISTRATION OF EFFECTIVE AMOUNTS OF FORMS OF HYALURONIC ACID
(FR) ADMINISTRATION PAR VOIE ORALE DE QUANTITES EFFICACES DE CERTAINES FORMES D'ACIDE HYALURONIQUE
Abstract
(EN)
This invention relates to the oral administration of forms of hyaluronic acid (for example hyaluronan (hyaluronic acid) and pharmaceutically acceptable salts thereof such as sodium hyaluronate), and orally administrable dosage forms containing forms of hyaluronic acid, for the prevention and/or treatment of diseases and/or conditions such as the prevention of restenosis andthe treatment of an infarct (heart attack) or a stroke. The oral administration and the orally administered dosage forms may also include therapeutic agents and/or medicines which may be administered orally for the treatment and/or prevention of the diseases and/or conditions with the forms of hyaluronic acid (hyaluronan) previously described.

Also published as
KR1019980704360
MXPA/a/1998/005588